January 2013 - Page 15 of 17

MondayJan 07, 2013 7:48 am

Talon Therapeutics, Inc. (TLON) Adds Elizabeth Weatherman to Board

Talon Therapeutics, Inc. (TLON) Adds Elizabeth Weatherman to Board Talon Therapeutics recently announced that Elizabeth Weatherman had been appointed to the company’s board of directors. Talon also announced the departure of Jonathan Leff, leaving the Talon board for Deerfield Management. Headquartered in San Francisco, CA, Talon is focused on the development of products intended for the therapy of hematologic malignancies and solid tumors, as well as a product candidate for the treatment-limiting skin toxicities of the EGFR-inhibitor class of cancer therapeutics. Weatherman is a Managing Director of Warburg Pincus (the majority shareholder of Talon), joining in 1988, and leads the…

FridayJan 04, 2013 2:48 pm

Viscount Systems, Inc. (VSYS) Appoints Dennis Raefield as COO

Dennis Raefield, previously President of Honeywell Access Systems and then CEO of Mace Security, recently became the COO of Viscount Systems, a global provider of advanced facility access control systems. Raefield, who has an extensive background in the security industry, has served on the Viscount board. At Honeywell Access Systems, a $100 million division of Honeywell International, Mr. Raefield was responsible for enterprise level access control systems for Fortune 100 clients. He was also the President of Pinkerton Systems Integration, currently Securitas, responsible for access control systems for Fortune 500 clients. Mr. Raefield was also CEO/owner of Omega Corporate Security,…

FridayJan 04, 2013 2:46 pm

Soligenix, Inc. (SNGX) Receives FDA Nod to Initiate Development Program of OrbeShield™

The Food and Drug Administration (FDA) has completed its review and given the go-ahead to Soligenix regarding its Investigational New Drug (IND) application for OrbeShieldTM (oral BDP), which is used to prevent death associated with the gastrointestinal acute radiation syndrome (GI-ARS). GI-ARS occurs after toxic radiation exposure and involves several organ systems, which can result in death within five to 15 days. To-date, there is no established treatment or preventive measure for the GI damage stemming from high-dose radiation exposure, though BDP has been marketed since the early 1970s as the active pharmaceutical ingredient in inhalation products for the treatment…

FridayJan 04, 2013 2:46 pm

Inergetics, Inc. (NRTI) Grabs Some Advertising Muscle Ahead of Big 2013 Brand Push

Inergetics, the nutritional supplement developer for the growing clinical health and sports supplement markets, reported today that the company has appointed award-winning outdoor advertising and marketing firm, AR James Media, Inc., founder, president, and CEO, James DeLucia, to the company’s Board. DeLucia brings an impressive track record to the company, having cut his teeth on the floor of the New York Mercantile Exchange in the late 80′s, before going on to form ALX Energy, Inc., after holding membership in two divisions on the COMEX (1992) and NYMEX (1999). The experience garnered at AR James Media by DeLucia, which specializes in…

FridayJan 04, 2013 8:06 am

Cardium Therapeutics, Inc. (CXM) Scheduled to Present at Biotech Showcase 2013 Investment Conference

Earlier this morning, Cardium Therapeutics announced that its CEO will be presenting at the Biotech Showcase 2013 Conference. This year the annual conference is being held January 7-9 at the Parc 55 Wyndham San Francisco Union Square Hotel. Cardium’s presentation will be available live and by replay. Those unable to attend will be able to access the executive presentation at http://phx.corporate-ir.net/phoenix.zhtml?c=77949&p=irol-calendar. Cardium will provide a corporate overview as well as a review of its entrepreneurial initiatives, which include strategic partner-enabled product and platform opportunities that have been internally developed based on Cardium’s unique skill set, capabilities, and technology. Current entrepreneurial…

FridayJan 04, 2013 8:06 am

Sernova Corp. (SVA.V) to Present at Upcoming Biotech Showcase 2013 Conference

Sernova Corp., a clinical-stage health sciences company focused on commercializing medical technologies, announced it will be presenting at the Biotech Showcase 2013 Conference, taking place Jan. 7-9, 2013, at Parc 55 Wyndham San Francisco – Union Square in San Francisco, Calif. Sernova’s presentation will be given on Monday, Jan. 7 at 1:45 p.m. Now in its fifth year, Biotech Showcase is an investor and partnering conference focused on providing private and public biotechnology and life sciences companies with the opportunity to meet with, and present to, investors and pharmaceutical executives in one location during one of the largest annual healthcare…

FridayJan 04, 2013 8:05 am

New Western Energy Corp. (NWTR) Announces Acquisition of 8 Leases Totaling 1,520 Acres and 106 Oil Wells

New Western Energy Corp., an independent energy company engaged in the acquisition, exploration, development, and production of oil, gas, and minerals primarily in North America, recently announced the completion of its acquisition of 8 oil and gas leases, which total 1,520 acres, with 106 oil wells and 8 disposal wells in Rogers County, OK. New Western purchased the leases from Pioneer Oil Development LLC. In addition to providing the development funds necessary to bring in to production the existing wells, New Western has stated that it intends to begin drilling additional wells upon completion of the workovers. The leases provide…

ThursdayJan 03, 2013 2:34 pm

Discovery Laboratories, Inc. (DSCO) Begins Initial Phase of AFECTAIR® Launch

Discovery Laboratories, a specialty biotechnology company dedicated to raising the standard in respiratory critical care, announced today that the launch of its AFECTAIR® airway connector has been initiated. The AFECTAIR® airway connector is designed for infants needing aerosolized medication in neonatal or pediatric intensive care units (NICU and PICU, respectively), and it simplifies medication delivery for those critical care patients who need ventilatory support. This simplification is provided through the innovative process of introducing the medication directly at the patient interface. The initial phase of the launch is the introduction of an AFECTAIR user experience program in leading U.S. critical…

ThursdayJan 03, 2013 2:33 pm

SunLink Health Systems, Inc. (SSY) Completes Sale of Assets of Missouri Hospital

SunLink Health Systems completed the sale of nearly all assets, and the leasehold interest of Dexter Hospital, LLC, to Southeast Health Center of Stoddard County, LLC. Southeast Health Center of Stoddard County is an indirect subsidiary of Southeast Missouri Hospital Association (D/B/A SoutheastHEALTH). The assets included a leased 50-bed acute care hospital and related clinics, equipment, and home health services in Dexter, MO. The sale of the assets and leasehold interest was for approximately $9.8 million, less estimated sale expenses and taxes. It is expected to result in net proceeds of approximately $7.4 million and an after tax gain of…

ThursdayJan 03, 2013 10:54 am

TNI BioTech, Inc. (TNIB) Scheduled to Present at 6th Annual OneMedForum Conference

TNI BioTech, a biotech company utilizing patented immunotherapy to activate and mobilize the body’s immune system to combat fatal diseases, today announced that CEO Noreen McGurrin Griffin and CMO Dr. Ronald Herberman will be speaking at the 6th Annual OneMedForum taking place in San Francisco, CA, on January 7-9, 2013. Ms. Griffin and Dr. Herberman will provide an update on the company’s business activities for 2012 as well as plans for 2013. TNI BioTech’s presentation is scheduled for Wednesday, January 9, 2013, at 11:20 am PST. For more information on TNI BioTech, visit www.TNIBioTech.com Let us hear your thoughts below:

Site Search

Company Search

Month: January 2013